Background: Current management of refractory benign oesophageal strictures with
| INTRODUCTION
Benign oesophageal strictures can be challenging to treat. The mainstay of treatment is endoscopic dilation. However, 30%-40% of these strictures recur despite rigorous dilations. 1 Although a consensus definition does not exist, a stricture is typically termed as a refractory benign oesophageal stricture when there is a failure to maintain luminal patency after at least five endoscopic dilations. 2, 3 These strictures are fibrotic and cicatricial, and are most commonly the sequelae of radiation, surgery, caustic ingestion or endoscopic mucosal resection. 4 Patients with refractory strictures are extremely difficult to manage and the current armamentarium includes repeated endoscopic dilations, injections of corticosteroid or mitomycin C, incisional therapy and/or temporary stent placement. [5] [6] [7] [8] [9] [10] Therapies for refractory strictures are costly, of limited long-term efficacy, and are associated with significant burden both for the patient and health care team. Despite multiple interventions, patients often still remain refractory and go on to require enteral nutrition support. The largest study on the natural history of refractory strictures found that the mean dysphagia free interval was 3 months, and only 2.4 months for patients treated with endoscopic stenting. The clinical success, defined as no need for endoscopic interventions for at least 6 months was 31% for the entire cohort and 12.5% for patients treated with stenting.
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Oesophageal self-dilation therapy, where the patient learns to pass a polyvinyl dilator orally on a routine basis, has been in practice since at least the 1970s. The largest study on self-dilation retrospectively studied 30 patients, 12 and all the prior studies combined included less than 50 patients in total. [12] [13] [14] [15] [16] [17] [18] [19] In these retrospective, observational studies, self-dilation appears to be effective for refractory strictures, reducing the number of endoscopic dilations from an average of 21.7 in the 12 months prior to self-dilation, to an average of one in the 12 months following self-dilation. 12 As self-dilation has been routinely used in our institution, we sought to report its efficacy and safety for treatment of refractory strictures.
The goals of our study were to assess the clinical outcome of self-dilation for patients with refractory strictures, by measuring an intervention free interval, and by comparing the dysphagia and number of endoscopic interventions before and after starting selfdilation. A secondary aim was to evaluate whether the aetiology or location of the stricture influenced the outcome of self-dilation.
Finally, we sought to assess the safety of self-dilation by identifying clinically significant adverse events. demographic and clinical data of each patient, including sex, age at diagnosis, stricture aetiology, stricture site and length, type and number of treatments applied, intervention-free intervals between treatments, final outcomes, and adverse events were extracted. Patients were excluded from the study if (1) they had less than 5 endoscopic dilations prior to starting self-dilation, (2) they could not complete the training process for self-dilation, (3) the length of follow-up was < 6 months (unless an adverse event occurred before then), (4) the stricture was angulated or associated with diverticulum, and self-dilation was not felt safe to perform and (5) the stricture showed malignancy on biopsy. Figure 1 summarises the selection process. The baseline date for analysis was considered to be the date of the initial visit for self-dilation at Mayo Clinic Rochester.
| PATIENTS AND METHODS

| Method of self-dilation
Information on self-dilation was reviewed with the patient during an office visit. Patients who agreed to undergo self-dilation underwent serial endoscopic dilations, where they were dilated 1-3 times a week to achieve a post-dilation luminal diameter of 10-18 mm. Immediately following the last endoscopic dilation, self-dilation was taught over 1-3 training sessions by one of two oesophageal physicians (JA and MH) and a nurse. The training sessions included detailed verbal instructions of the dilation process and familiarisation with the dilation equipment.
weekly phone calls from the oesophageal nurses. Information on resistance with passing the dilator, as well as a standard set of questions on dysphagia symptoms, quality of life, and patient preference were collected by the nurses and on follow-up visits (Data S1).
| Outcomes
The primary outcome of this study was clinical success of self-dilation defined as an intervention free interval greater than 6 months and an improvement in the Dakkak Bennett Dysphagia Score 24 by at least 1 point. The intervention free interval was the maximum number of days between two endoscopic interventions after starting self-dilation. For patients who did not require any further interventions after self-dilation, this interval was the number of days between their last endoscopic procedure before self-dilation, and the date of last follow-up. The number of endoscopic interventions was used as another variable of efficacy, and this was compared before and after initiating self-dilation. Stricture aetiologies and locations were collected as independent covariates on the outcomes.
We reviewed notes from two oesophageal physicians to calculate the dysphagia score, which was defined as follows: 0, no dysphagia; 1, dysphagia to solids; 2, dysphagia to semi-solids; 3, dysphagia to liquids; 4, aphagia. Dysphagia score from before to after starting self-dilation were compared. Finally, the presence or removal of a feeding tube was used to assess the impact of selfdilation on the patient's ability to maintain oral nutrition.
Serious adverse events, defined as any adverse event that required or extended the patient's hospital stay, additional endoscopic or surgical treatment, or caused death, 20 were recorded. All outside materials available through the electronic medical record was reviewed to account for endoscopic interventions and adverse events, outside of the Mayo Clinic.
| Statistical analysis
Baseline characteristics were summarised using median, interquartile interval, and range for continuous variables if the distribution was skewed, and percentage for nominal ones. We compared the various measures of efficacy (number of endoscopic procedures and dysphagia score) using a two-tailed paired Student's t test. Kaplan-Meier curves were used to demonstrate the outcomes of self-dilation visually. A two-sided P value of 0.05 was considered statistically significant. All statistical analysis was performed in JMP Pro 13 (SAS Institute Inc., Cary, USA.)
3 | RESULTS
| Study population
We identified and included 52 patients with refractory strictures treated with self-dilation. Data on clinical characteristics, stricture aetiology and location are presented in Table 1 . Forty-two (81%) of these EMR query of "self dilation" + "Maloney" + "esophageal" Refractory benign esophageal strictures started on self-dilation (n = 52) All strictures were endoscopically dilated to a median diameter of 15 mm (range 14-18 mm) at start of self-dilation, and the median initial dilator size was 12 mm (range 11-13 mm).
Only one of 52 patients was not able to continue self-dilation due to pain and bleeding 3 days after graduating from the programme, the remaining 51 patients all preferred self-dilation to endoscopic dilation. Of the 98 patients that we offered self-dilation to, only four declined after watching the instructional video, 25 and five patients were not able to be trained successfully for independent self-dilation (Figure 1 ).
| Effectiveness of self-dilation
Self-dilation effectively reduced the median number of endoscopic interventions from 9.5 (range 5-30) within 12 months before, to 0 (range 0-3) within 12 months after starting self-dilation, P < 0.0001.
The all-time median number of endoscopic interventions was reduced from 11 (range 5-57) to 0 (range 0-5), P < 0.0001. Table 2 shows the median and mean numbers of endoscopic interventions before and after self-dilation with regards to stricture characteristics.
At median follow-up of 541.5 days, about 80% of the patients were alive and free from endoscopic intervention (Figure 2 ).
Self-dilation produced a median intervention free interval of 417 days (IQR 256-756 days), and clinically successful as defined by intervention-free interval>6 months and reduction in dysphagia score by at least one point in 46 patients (88%).
Of the six (12%) patients that did not reach clinical success, all failed because an endoscopic intervention was done within 6 months of starting self-dilation. Five of the six patients had an interruption to self-dilation that led to recurrent dysphagia (1 due to hospitalisations unrelated to refractory strictures, three due to pain and bleeding, and one patient had decreased the frequency of selfdilation prematurely on their own). On the first repeat endoscopy, the stricture diameter was within 2 mm of the dilator size in four of six patients.
The mean dysphagia score at baseline was 2.5 (95% CI 2.2-2.8).
After serial endoscopic dilations, this decreased to a mean of 0.8 (95% CI 0.60-1.02) at start of self-dilation, and finally to a mean of 0.33 (95% CI 0.11-0.53) on last follow-up after starting self-dilation.
The mean reduction in dysphagia score was 2.21 (95% CI 1.83-2.59).
Twenty-seven or 52% of the patients required enteral nutrition via a gastric or jejunal feeding tube prior to starting self-dilation. At last follow-up, all of these patients were taking in solid food orally, and 23 (85%) had their feeding tubes removed.
Twenty patients had been on opioids at the time of self-dilation, eight were on benzodiazepines, and six were on both. Four patients had been seeing psychiatry for depression and anxiety. There was no significant effect of psychotropic medication and psychiatric history on the intervention-free-interval after self-dilation (P = 0.89, P = 0.46, P = 0.90, for opioid, benzodiazepine, and psychiatric history respectively).
| Durability of self-dilation
Thirty-six patients had follow-up >1 year with median follow up of 868 days (IQR 748-1668). Twenty-eight of these patients were still self-dilating, whereas eight patients were no longer requiring selfdilation. Of the 28 patients who were still self-dilating, 1 was dilating twice a day, 11 daily, 2 every other day, 2 every third day, 5 weekly, 2 every other week and 5 monthly. Fifteen patients had interruptions or weaned off self-dilation before 1 year. All of these patients developed recurrent strictures and required endoscopic dilation to restart self-dilation.
| Effect of stricture aetiology and location
The number of endoscopic interventions was significantly reduced across all stricture aetiologies (Table 2) . A higher proportion of distal strictures required endoscopic interventions compared to other locations, however, this difference was not statistically significant The stricture developed due to either procedure or injury from benign causes.
(P = 0.59). Similarly, there was no statistically significant difference in outcomes for strictures from different aetiologies (P = 0.68).
| Safety and adverse events
Few clinically significant adverse events occurred and are summarised in Table 3 . One patient's death may have been related to self-dilation. This patient had been receiving self-dilation from his spouse twice a day for 20 days for a radiation-induced cricopharyngeal stricture when he gradually developed pain and resistance with passing the dilator. Self-dilation was stopped and he underwent an EGD which showed severe candidal oesophagitis and a recurrent
stricture. An endoscopic dilation was performed and self-dilation was not resumed. 48 hours later, while an in-patient for hydration, the patient developed hypopharyngeal haemorrhage that resulted in aspiration and death. No autopsy was performed. Otherwise, two additional clinically significant events of bleeding occurred: one patient was on fondaparinux, the other had no apparent risk factors.
Both were treated conservatively. A total of eight (15%) patients were on low-dose aspirin, and 6 (11%) were therapeutically anticoagulated. No clinically apparent perforation occurred. Minor adverse reactions such as pain, GERD, oesophageal ulcer and oesophagitis was reported in 25 (48%) of the patients.
| DISCUSSION
Our study shows that self-dilation is effective for treatment of refractory strictures, with outcomes far superior to that observed in a multicentre, international retrospective review of 70 patients with refractory strictures who were not offered self-dilation, where clinical resolution of dysphagia only occurred in 31%. 11 Using the same definition for clinical resolution of dysphagia as that study, we found self-dilation to be clinically successful in 88% overall. We observed a dramatic reduction in number of interventions from a median number of 9.5 to 0 within 1 year after starting self-dilation. In addition, self-dilation was successful at reducing symptoms of dysphagia.
Remarkably, although half of the patients required enteral nutrition prior to self-dilation, all these patients resumed the ability to sustain oral nutrition after self-dilation and most patients had their enteral feeding tube removed.
Historically, refractory strictures have been found to recur despite frequent endoscopic dilations, corticosteroid injections and electrocautery, and stents are therefore often employed in an attempt to relieve symptoms. However, outcomes with stenting are dismal at best with a success rate between 14% and 33% and complications rate of 11% including a stent migration rate of 14%-32%. 21 Indeed, in the study by Repici et al, endoscopic stenting led to an intervention free period of only 2.4 months, whereas self-dilation led to an intervention free interval of over 12 months in our study.
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Although an intervention free interval has been routinely reported for other endoscopic procedures such as stenting and steroid injections, it has never previously been reported for self-dilation.
Therefore, our study provides a common unit of measure for comparing the effectiveness of self-dilation with conventional therapy for refractory strictures, as well as an informative tool for the provider when discussing chances of needing an endoscopy in 6 months with the patient. Compared to prior, smaller studies of self-dilation, our clinical success rate was slightly lower (88% vs 90% 12 and 100% 13 ). We suspect this is in part due to our very strict definition
The all-time number of endoscopic interventions before and after starting self-dilation, with relation to stricture location and aetiology of clinical success, incorporating not only symptoms of dysphagia, but also an intervention free interval of >6 months. Furthermore, we systematically sought information with regards to endoscopic procedures performed at other institutions during the follow-up period for the 30% of our patients who did not receive primary gastroenterology care at our institution, which was not reported in earlier studies at similar referral centres. Even for patients who required repeat endoscopy during the follow-up period, stricture patency was adequately maintained in most patients suggesting that luminal patency was not the primary driver of their ongoing symptoms. In addition, while self-dilation experience has previously been reported for proximal and mid-oesophageal strictures, little was known about efficacy for distal oesophageal strictures. In our study, five patients with distal strictures appeared to have outcomes comparable to other locations.
Self-dilation appears to have an acceptable safety profile. There was one potential self-dilation-related death due to bleeding and aspiration. While it is conceivable that self-dilation contributed to this event, it is hard to draw any conclusions as the patient also received endoscopic dilatation 2 days prior. In the study by Repici et al, 12 of 70 patients died and two of these were directly attributed to the endoscopic intervention including stenting. Therefore, the risk associated with self-dilation therapy appears comparable to the endoscopic procedures otherwise used to manage refractory strictures. 11, 22 We observed that self-dilation was well-tolerated and patients almost unanimously preferred self-dilation to endoscopic dilation, once they graduate to independent self-dilation. If resistance with passing the dilator, pain or bleeding occurs, this would have led to discontinuation or change in therapy as reported in results. The most common adverse events included reflux symptoms, and patients should be educated on anti-reflux lifestyle modifications at initiation of self-dilation. All patients symptomatic from reflux responded well to PPI therapy.
While self-dilation is well-tolerated by most patients, it is important to note that our patients were carefully selected, and were given sufficient mental preparation and training prior to starting self-dilation.
The biggest anxiety that patients faced was the uncertainty of whether they would be able to pass the dilator. The aforementioned instructional video was instrumental at helping patients overcome this fear, as it showed patients of all demographics successfully passing the dilator with no discomfort. Our training sessions were then individualised to the needs of the patient, more sessions and closer follow-up were needed by some patients. A topical lidocaine spray was provided to all patients at the start of self-dilation, and over the period of a month, most patients became proficient at self-dilating and no longer required the topical anaesthetic.
In our experience, we have avoided self-dilation in patients with angulated strictures or distal oesophageal diverticula, as fluoroscopy has shown that the blind Maloney dilator can get coiled proximal to the stricture, making self-dilation ineffective and unsafe. We therefore, would not recommend self-dilation in patients with angulated strictures or those associated with a distal oesophageal diverticulum.
Although there was no significant association between use of psychotropic medications and psychiatric history with the effect of self-dilation, we must caution that this study is retrospective, and all patients were carefully selected and were motivated participate in self-dilation after 2-3 training sessions.
Despite being in practice for decades, we feel that self-dilation is an under-recognised treatment of refractory strictures. 23 Although there is no definitive evidence as to why self-dilation is not more frequently used, we believe this may be a result of a lack of awareness and training in self-dilation and lack of evidence in the field of self-dilation. We found that most patients at ages between 18 and 87 were able to master the skill of self-dilation and only five of 98 patients could not be successfully trained. Although bougie dilations are no longer taught universally, the technique of self-dilation for the physician can be readily learnt through previously described methods and an online instructional video from the ASGE. The dysphagia score was retrospectively obtained from follow-up visit notes. However, this could be partially ameliorated as all the patients were seen by two oesophageal physician (JA and MH), who collected the dysphagia history in a systematic method. In addition, 30% of our patients received care outside of our institution. While we reviewed outside medical records, we may still have missed endoscopic interventions that were outside of our medical centre. In addition, although our study is the largest series for self-dilation in the treatment of refractory strictures, we were still limited in our sample size of 52, which made our analysis of confounding variables difficult. Finally, our data do not apply to patients with severely angulated strictures and distal oesophageal diverticula as such patients were excluded from self-dilation in our study.
T A B L E 3 Clinically significant adverse events for patients on self-dilation 
